After the Last Rocket: How Bonfire Smoke Keeps Airway Signalling on Edge

The morning after Bonfire Night can look reassuringly clean. The ash has settled, the rockets have stopped, and the streets are quiet. Yet the air may still carry a burden of fine particulate matter, and the airway has already begun to respond. For most people the consequence is a transient cough or a scratchy throat. For people with asthma or chronic obstructive pulmonary disease, the effects can outlast the fireworks by several days. The reason lies not simply in irritation but in a cascade of cellular signalling that reprograms the airway's alarm system.

A plume with a chemical signature

Bonfire smoke is a heterogeneous mixture. It contains fine and ultrafine particles, polycyclic aromatic hydrocarbons, aldehydes such as acrolein, and trace metals. The smallest particles penetrate beyond the upper airway and deposit in bronchioles and alveoli, where they can interact with epithelial cells and alveolar macrophages. Unlike a simple inert dust, this mixture carries chemical reactivity. Aldehydes and oxidants can modify proteins and lipids, while particle surfaces can generate reactive oxygen species. The airway therefore encounters not one signal but a complex pattern of danger-associated molecular patterns and oxidative cues.

The epithelium raises the alarm

Airway epithelial cells are not a passive barrier. They express sensory receptors, including TRPA1, a non-selective cation channel activated by a range of irritants such as acrolein and by oxidative stress. Activation of TRPA1 and related pathways increases intracellular calcium and triggers release of ATP, cytokines and chemokines. Epithelial cells also release alarmins such as IL-25, IL-33 and TSLP, which can act on innate lymphoid cells and dendritic cells. In parallel, oxidative stress activates the transcription factor Nrf2, which drives antioxidant and detoxifying enzymes. This is a protective response, but it is not unlimited. When the oxidant load is high, pro-inflammatory signalling through NF-kB and related pathways can predominate, tightening the epithelial barrier, increasing mucus production and recruiting immune cells.

Macrophages as cleaners and commentators

Alveolar macrophages phagocytose particles and debris, but they also interpret the chemical context. Exposure to smoke-derived material can promote release of TNF, IL-1beta, IL-6 and further reactive oxygen species. Macrophages help to clear the burden, yet their activation also shapes the wider inflammatory conversation. In people with asthma or COPD, macrophage function may already be altered, and the balance between resolution and persistent inflammation can shift. The result is not a single burst of irritation but a sustained signalling environment in which repair and inflammation compete.

Nerves, cough and bronchoconstriction

Sensory nerves in the airway provide another layer of surveillance. Vagal C-fibres express TRPA1 and TRPV1, and smoke-derived irritants can activate them directly or sensitise them indirectly through inflammatory mediators. Activation leads to cough and, through local axon reflexes, release of neuropeptides such as substance P and CGRP. These peptides can amplify plasma leakage, mucus secretion and bronchoconstriction. In an airway already primed by asthma or COPD, the threshold for nerve firing may be lower, so a smaller stimulus produces a larger response. This helps explain why symptoms can persist after the visible smoke has gone.

Why the effects can outlast the bonfire

Inflammation is not switched off instantly when exposure ends. Resolution is an active process involving lipid mediators, anti-inflammatory cytokines and clearance of dead cells. Fine particles can remain in the lung for hours to days, and oxidative stress can continue as cells repair damaged membranes and proteins. Epithelial injury may transiently impair barrier function, while macrophage activation and nerve sensitisation can persist. In asthmatic airways, increased mucus and bronchial hyperresponsiveness may prolong wheeze and cough. In COPD, impaired antioxidant defences and structural changes can make the response more prolonged. The clinical lesson is that the risk window extends beyond the night itself.

What the evidence says about protection

The most reliable advice is to reduce exposure. During and after Bonfire Night, people with respiratory disease should follow their written action plan, keep reliever inhalers accessible and take preventer medication as prescribed. Staying indoors with windows closed during peak smoke, and using recirculation in vehicles, can lower exposure. Well-fitted respiratory masks may reduce particle inhalation, but evidence for cloth coverings is limited and no mask eliminates exposure. Antioxidant supplements have been proposed as protection, yet clinical evidence that they prevent smoke-related airway inflammation is weak; they should not substitute for avoidance and prescribed treatment.

What the evidence does not support is the idea that a single intervention can undo the signalling effects of smoke. The airway response is distributed across epithelial sensors, macrophages and nerves, and it unfolds over time. For patients and clinicians, the practical message is vigilance rather than reassurance. If symptoms worsen after Bonfire Night, particularly with increased wheeze, breathlessness or reduced reliever response, medical advice should be sought. The rockets may be over, but the cellular conversation they started can continue for days.